Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)

This study has been terminated.
(Just Terminated for the end of the pandemia)
Sponsor:
Collaborators:
Hoffmann-La Roche
GlaxoSmithKline
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00799760
First received: November 28, 2008
Last updated: March 16, 2012
Last verified: November 2008